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Abstract 
In light of growing interest for three-dimensional printing technology in the 
cardiovascular community, this study focused on exploring the possibilities of 
providing training for cardiovascular three-dimensional printing in the context of a 
relevant international congress and providing considerations on the delivery of 
such courses. As a second objective, the study sought to capture preferences in 
relation to three-dimensional printing uses and set-ups from those attending the 
training session. A survey was administered to n = 30 professionals involved or 
interested in three-dimensional printing cardiovascular models following a 
specialised teaching session. Survey results suggest the potential for split training 
sessions, with a broader introduction for those with no prior experience in three-
dimensional printing followed by a more in-depth and hands-on session. All 
participants agreed on the potential of the technology in all its applications, 
particularly for aiding decision-making around complex surgical or interventional 
cases. When exploring setting up an in-house three-dimensional printing service, 
the majority of participants reported that their centre was already equipped with an 
in-house facility or expressed a desire that such a facility should be available, with 
a minority preferring consigning models to an external third party for printing. 
Keywords Paediatric cardiac surgery, artificial kidney, apheresis & detoxification 
techniques, cardiac imaging, cardiac surgery, modelling 
cardiovascular, bioengineering 
  
Introduction 
Three-dimensional (3D) printing is increasingly recognised as a valuable tool in 
cardiac surgery and cardiology, and particularly in congenital heart disease 
(CHD), where the anatomical variability between patients and the complexity of 
surgical/interventional repairs warrants a patient-specific approach.1,2 The 
technology allows retaining patient-specific features through the manufacture of 
models that have been generated via image segmentation and volume rendering 
processing. These start from routinely acquired medical imaging data such as 
cardiovascular magnetic resonance (CMR) imaging or computed tomography 
(CT), and more recently also technologies such as 3D echocardiography and 
micro-CT.3,4 The availability of such CHD models opens the door to multiple 
applications, ranging from aiding the decision-making process for 
surgical/interventional planning to counselling families and communication with 
young people, and from medical education and training to designing experimental 
setups for researching specific CHD scenarios.5–11 Multiple case studies, case 
series and a few randomised studies have begun to gather evidence with regards 
to these different applications and discuss the usefulness of 3D printing as a tool 
complementing multimodality imaging for complex CHD cases, as a means of 
engaging patients and enabling them to gain confidence about their condition or 
exploring their own narratives of illness or as guides for preoperatively planning 
tumour debulking in infants highlighting the spatial relationship between the 
tumours and coronary arteries.12–14 Alongside such growing interest in the clinical 
community and increasing recognition of the possibilities offered by 3D printing 
technology, methodological advances are rendering image-processing faster and, 
especially, the technology itself more accessible, with affordable desktop 3D 
printers able to produce models of very good quality for the applications outlined 
above. As a result of the growing interest in the CHD community and the 
increasing availability of the technology, new questions arise, including around 
standardisation of methodologies, training provision and possible configuration of 
3D printing services. Guidelines for medical 3D printing and appropriateness for 
clinical scenarios are beginning to emerge,15promoted by new dedicated special 
interest groups in relevant societies, such as the Radiological Society of North 
America (RSNA) 3D printing Special Interest Group (https://www.rsna.org) or the 
new Society for Cardiovascular Magnetic Resonance (SCMR) 3D + working group 
(https://www.scmr.org). Practical guides and primers are also appearing to 
provide information and guide practitioners with an interest in cardiovascular 3D 
printing.16–18 In this light, we sought to explore further the possibilities of providing 
training for cardiovascular 3D printing in the context of a relevant international 
congress and provide considerations on the delivery of such courses. As a 
second objective for this study, we sought to capture preferences in relation to 3D 
printing uses and set-ups from those attending the training session. 
  
Methods 
Training session and participants 
A 1.5 h long 3D printing training session titled ‘From 2D images to 3D models’ was 
organised in the context of the 2018 EuroCMR/SCMR joint congress (31 January 
– 3 February 2018, Barcelona, Spain). The congress was attended by clinicians 
performing CMR (cardiologists or radiologists), technologists, physicists and 
engineers from 70 countries. The training session was advertised prior to the 
meeting on the congress webpage and via email, and all congress attendees 
could register in advance for the session free of charge. The session was 
delivered by two biomedical engineers (G.B., S.S.) with a cardiologist (E.G.M.) 
and it was repeated twice to allow for flexibility within the conference programme. 
Course delivery 
The course provided 
 (a) an overview of the principles of 3D printing, with minimal background on 
the evolution of the technology particularly in relation to biomedical 
applications and cardiovascular applications more specifically; 
 (b) an overview of the workflow (Figure 1) from image acquisition and 
segmentation to model printing and cleaning, including different segmentation 
strategies and key design considerations; 
 (c) practical considerations including an overview of software packages and 
open-source solutions currently available for image processing, materials 
compatible with the technology and related costs, and printers currently 
available on the market and related costs; 
 (d) a description of main current cardiovascular applications of the technology, 
including decision-making, device testing, first-in-man procedures, building 
experimental setups, communicating with patients and training clinical staff, 
presenting one or more relevant examples for each through real cases and/or 
completed studies. 
 Figure 1. The teaching session included discussing different steps of the current 
(left) workflow for 3D printing cardiovascular models from image acquisition to 
printing, as well as discussing possible optimisation of the workflow (right). The latter 
would entail reducing the time for, and amount of, manual editing of the 3D computer 
model prior to finalising and exporting to the printer, but also implementing more 
robust automatic segmentation techniques, and potentially reducing printing time 
itself (depending on the available printing technology). 
These elements of the course were delivered in lecture-style, followed by 
presenting the participants with a range of 3D printed models of paediatric and 
adult CHD cases. Models depicted real-life cases based on either CT or CMR 
data reconstructed using commercial software (Mimics, Materialise, Leuven, 
Belgium; Simpleware, Simpleware Ltd., Exeter, UK), and they were not all printed 
on the same machine. In fact, in order to provide a broad overview, participants 
were shown a selection of fused deposition modelling (FDM), selective laser 
sintering (SLS), stereolithography (SLA), TangoPlus FullCure® and silicone 
models. Models had been printed previously for different applications and the 
selection included 15 models, focusing on the technical features of the models 
rather than on the medical history or clinical characteristics of each case. Models 
were used to present to participants different printing options, including different 
colours (e.g. white, transparent, red-and-blue and other colours), different 
materials (e.g. rigid resin, compliant rubber-like resin and powder-based 
materials) and different configurations of the models depending on the defect(s) of 
interest (e.g. being able to open up a model and observing intra-cardiac anatomy 
vs full solid model to appreciate size and position of great vessels, including the 
possibility of using magnets to hold different parts of the model together). To 
conclude, a case study was presented to summarise the workflow, from case 
presentation and request of model from the surgeon to model-making and 
printing, including feedback from different users.19 
Survey and analysis 
A short survey comprising of eight questions and designed to be completed in 5–
10 min was administered at the end of the session, to capture participants’ 
preferences in relation to course delivery and 3D printing training as well as 
participants’ views on access to and applications of the technology. The survey 
asked for the participants’ professional background and prior experience with 3D 
printing (if any), the usefulness of the provided training session (on a 5-point 
Likert-type scale from ‘Not useful at all’ to ‘Extremely useful’) and the desire for 
more training (yes/no answer), including the possibility of longer sessions (yes/no 
answer) and/or more real-life demonstrations with live model reconstructions. The 
survey also asked participants for their interest in implementing 3D printing in their 
practice (answer options: ‘Not interested’, ‘Not interested but it’s cool’, ‘Interested 
but no set-up available’, ‘Interested but not enough time’ (to implement it), 
‘Interested’) and indicating the areas they considered more relevant in terms of 3D 
printing applications, checking one or more options from ‘Communication’, 
‘Training/teaching’, ‘Clinical’ and ‘Research’. Finally, in order to explore different 
possible set-ups for a 3D printing service, the survey asked participants whether 
their Centre should be equipped with 3D printing facilities (answer options: ‘Yes it 
already has one’, ‘Yes, it should have one’, ‘No, models could be consigned 
outside for printing’ and ‘Not sure’). Survey results are presented as counts and 
proportions. 
  
Results 
The 3D printing session was attended by 30 congress participants, of whom 28 
completed the survey (93% response rate). Survey responders had a mix of 
professional backgrounds related to cardiovascular imaging, reflecting the nature 
of the conference, including CMR fellows/consultants (n = 6) and cardiologists 
(n = 12), technologists (n = 2), radiologists (n = 5), bioengineers (n = 2) and 
physicists (n = 1). Participants reported to already have some experience with 3D 
printing in 39% of the cases, and the majority (79%) expressed interest for 
additional training. While a large proportion (77%) rated the course as ‘very useful’ 
or ‘extremely useful’ in its current format and no one rated it as ‘not useful’, 30% 
of participants expressed desire for longer training sessions and an additional 
29% for longer training sessions including live reconstructions. However, 41% of 
participants considered the course a sufficient introductory session in its format. 
Considering participants’ interest in implementing 3D printing in their practice 
(Figure 2), all participants confirmed they would be interested, with most (69%) 
agreeing on the potential of the technology, and the remainder also agreeing but 
reporting either not having access to the technology (27%) or not having enough 
time to dedicate to 3D printing work/research (4%). Participants rated 3D printing 
as useful for developing research projects (68%), talking to patients (71%), 
training staff/students (75%) and particularly for gaining additional insight in 
clinical cases (78%), with 50% of participants ticking all four available options. 
Finally, when exploring the need for setting up and having access to an in-house 
3D printing service, participants mostly confirmed that their centre is either already 
equipped (39%) or it is currently not equipped, but they felt it would be 
advantageous if it were (38%). Only 8% participants indicated a preference for 
consigning model printing to a third party, with 15% remaining undecided. 
 Figure 2. Capturing participants’ preferences in relation to availability of a 3D 
printing in-house service (top) and current availability of or desire for an in-house 3D 
printing service versus consigning model printing to an external third party (bottom). 
  
Discussion 
A relatively short teaching session focused on cardiovascular 3D printing, which 
can be incorporated in the context of an international cardiovascular imaging 
congress, where attendees of different professional backgrounds would likely be 
interested in receiving training on this topic, considering its growing use in clinical 
practice and research. In our case, the session was attended by cardiologists and 
imagers as well as technologists and engineers. Professionals with an interest in 
cardiovascular 3D printing were satisfied with a general introductory session 
delivered in lecture-style, covering some theoretical aspects, but also 
summarising practical considerations on image segmentation (and related 
software), available materials and associated costs, together with an overview of 
the different applications of the technology. This session was particularly geared 
towards CHD applications, but an accent could also be put on cardiovascular 
devices and valves,20 on phantom building and experimental setups, or on patient 
engagement,21 depending on the specific audience. 
Our survey revealed that a proportion of participants would have attended a 
longer session, not only including more in-depth discussion of applications and 
technical tips, but also including live 3D reconstructions of cases. This suggests 
the potential for a split training session, with a broader introduction for those with 
no prior experience in 3D printing but wanting to understand the requirements of 
implementing the technology at their centre and the basic workflow, followed by a 
more in-depth and hands-on session where users with some experience could 
work more interactively on a live case. The latter would imply some degree of 
preparation before the course, with those interested in the hands-on component 
attending with a laptop and ensuring the same software was made available to all 
participants, as well as one or more practice cases. 
When considering the different applications of the technology, half of the 
participants in this survey highlighted the versatile nature of 3D printing in 
cardiology and cardiac surgery, recognising possible uses for clinical decision-
making, training, communication with patients and research. Overall, the use of 
models for gaining insight into complex cases was rated as the most valuable 
application of the technology, in part possibly reflecting the nature of the 
audience. Furthermore, participants unanimously agreed that it would be valuable 
to implement 3D printing in their practice. When exploring the possibility of setting 
up, it emerged that in the majority of cases either participants reported that their 
centre was already equipped with an in-house facility or they expressed a desire 
that such a facility should be available, with a minority being indecisive with 
regards to the optimal set-up or preferring consigning models to an external third 
party for printing. This is reflective of the increased access to and affordability of 
the technology in recent years, which currently enables a clinical centre to 
purchase 3D printing equipment with a more modest investment than just 
10 years ago. However, considerations about set-up should also include staffing 
such a facility and/or collaborations with relevant parties (e.g. biomedical 
engineers or specialised technicians), as well as governance questions and 
reimbursement issues depending on different systems. While the survey aimed to 
capture participants’ preferences with regards to in-house printing facilities, the 
session did not include a full analysis of the costs associated with setting one up. 
Costs of different materials and printers were presented as part of the session, but 
other factors (such as person time associated with running an in-house facility) 
were not discussed, as these were beyond the purposes and scope of the 
teaching session. These are nevertheless important considerations that, together 
with a centre’s own assessment of their volume of cases, should inform their 3D 
printing strategy. 
The limitations of this study include a small sample, limiting the generalisability of 
the findings and the ability to undertake any sub-group analyses, and a possible 
selection bias, with congress attendees with an existing interest or curiosity 
towards the subject of 3D printing potentially being more likely to participate in the 
teaching session. 
In conclusion, this survey indicated that an effective way to deliver a teaching 
session on 3D printing would likely include an element delivered in lecture-style 
and a second, possibly optional, element with more hands-on activities, including 
image segmentation. Furthermore, a move towards in-house implementation of 
3D printing services and/or a desire for in-house 3D printing facilities suggests 
that this technology may increasingly become an additional tool alongside 
multimodality imaging, gradually translating into clinical practice. 
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